140 related articles for article (PubMed ID: 24574286)
1. Demonstration of plasmid-mediated drug resistance in Mycobacterium abscessus.
Matsumoto CK; Bispo PJ; Santin K; Nogueira CL; Leão SC
J Clin Microbiol; 2014 May; 52(5):1727-9. PubMed ID: 24574286
[TBL] [Abstract][Full Text] [Related]
2. Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents.
Yoshida S; Tsuyuguchi K; Suzuki K; Tomita M; Okada M; Hayashi S; Iwamoto T; Saito H
Int J Antimicrob Agents; 2013 Sep; 42(3):226-31. PubMed ID: 23850022
[TBL] [Abstract][Full Text] [Related]
3. Rapid tests for the detection of the Mycobacterium abscessus subsp. bolletii strain responsible for an epidemic of surgical-site infections in Brazil.
Matsumoto CK; Chimara E; Ramos JP; Campos CE; Caldas PC; Lima KV; Lopes ML; Duarte RS; Leão SC
Mem Inst Oswaldo Cruz; 2012 Dec; 107(8):969-77. PubMed ID: 23295745
[TBL] [Abstract][Full Text] [Related]
4. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.
Bastian S; Veziris N; Roux AL; Brossier F; Gaillard JL; Jarlier V; Cambau E
Antimicrob Agents Chemother; 2011 Feb; 55(2):775-81. PubMed ID: 21135185
[TBL] [Abstract][Full Text] [Related]
5. Molecular identification and typing of Mycobacterium massiliense isolated from postsurgical infections in Brazil.
Monego F; Duarte RS; Nakatani SM; Araújo WN; Riediger IN; Brockelt S; Souza V; Cataldo JI; Dias RC; Biondo AW
Braz J Infect Dis; 2011; 15(5):436-41. PubMed ID: 22230849
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae.
Aono A; Morimoto K; Chikamatsu K; Yamada H; Igarashi Y; Murase Y; Takaki A; Mitarai S
J Infect Chemother; 2019 Feb; 25(2):117-123. PubMed ID: 30447882
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and molecular characterization of quinolone resistance in Mycobacterium abscessus subsp. bolletii recovered from postsurgical infections.
de Moura VCN; da Silva MG; Gomes KM; Coelho FS; Sampaio JLM; Mello FCQ; Lourenço MCDS; Amorim ELT; Duarte RS
J Med Microbiol; 2012 Jan; 61(Pt 1):115-125. PubMed ID: 21903825
[TBL] [Abstract][Full Text] [Related]
8. Predominance of clarithromycin-susceptible Mycobacterium massiliense subspecies: Characterization of the Mycobacterium abscessus complex at a tertiary acute care hospital.
Chew KL; Cheng JWS; Hudaa Osman N; Lin RTP; Teo JWP
J Med Microbiol; 2017 Oct; 66(10):1443-1447. PubMed ID: 28874233
[TBL] [Abstract][Full Text] [Related]
9. Subspecies distribution and macrolide and fluoroquinolone resistance genetics of Mycobacterium abscessus in Korea.
Kim J; Sung H; Park JS; Choi SH; Shim TS; Kim MN
Int J Tuberc Lung Dis; 2016 Jan; 20(1):109-14. PubMed ID: 26688536
[TBL] [Abstract][Full Text] [Related]
10. Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii).
Lee MR; Tsai HY; Cheng A; Liu CY; Huang YT; Liao CH; Liang SK; Lee LN; Hsueh PR
J Clin Microbiol; 2012 Nov; 50(11):3754-6. PubMed ID: 22933592
[TBL] [Abstract][Full Text] [Related]
11. Rapidly growing mycobacteria in Singapore, 2006-2011.
Tang SS; Lye DC; Jureen R; Sng LH; Hsu LY
Clin Microbiol Infect; 2015 Mar; 21(3):236-41. PubMed ID: 25658536
[TBL] [Abstract][Full Text] [Related]
12. Detection and assessment of clarithromycin inducible resistant strains among Korean Mycobacterium abscessus clinical strains: PCR methods.
Lee SH; Yoo HK; Kim SH; Koh WJ; Kim CK; Park YK; Kim HJ
J Clin Lab Anal; 2014 Sep; 28(5):409-14. PubMed ID: 24652818
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium bolletii respiratory infections.
Adékambi T; Drancourt M
Emerg Infect Dis; 2009 Feb; 15(2):302-5. PubMed ID: 19193279
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.
Cavusoglu C; Gurpinar T; Ecemis T
New Microbiol; 2012 Jan; 35(1):73-6. PubMed ID: 22378556
[TBL] [Abstract][Full Text] [Related]
15. Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies.
Mougari F; Bouziane F; Crockett F; Nessar R; Chau F; Veziris N; Sapriel G; Raskine L; Cambau E
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799212
[TBL] [Abstract][Full Text] [Related]
16. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Gui J; Wang F; Hong CY; Li JL; Liang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
[TBL] [Abstract][Full Text] [Related]
17. Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii.
Zelazny AM; Root JM; Shea YR; Colombo RE; Shamputa IC; Stock F; Conlan S; McNulty S; Brown-Elliott BA; Wallace RJ; Olivier KN; Holland SM; Sampaio EP
J Clin Microbiol; 2009 Jul; 47(7):1985-95. PubMed ID: 19420162
[TBL] [Abstract][Full Text] [Related]
18. Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus.
Maurer FP; Castelberg C; Quiblier C; Böttger EC; Somoskövi A
J Antimicrob Chemother; 2014 Jun; 69(6):1559-63. PubMed ID: 24500188
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium abscessus: a new antibiotic nightmare.
Nessar R; Cambau E; Reyrat JM; Murray A; Gicquel B
J Antimicrob Chemother; 2012 Apr; 67(4):810-8. PubMed ID: 22290346
[TBL] [Abstract][Full Text] [Related]
20. gyrA and gyrB gene mutation in ciprofloxacin-resistant Mycobacterium massiliense clinical isolates from Southern Brazil.
Monego F; Duarte RS; Biondo AW
Microb Drug Resist; 2012 Feb; 18(1):1-6. PubMed ID: 21711149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
